País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
desmopressin acetate (UNII: XB13HYU18U) (desmopressin - UNII:ENR1LLB0FP)
Sagent Pharmaceuticals
INTRAVENOUS
PRESCRIPTION DRUG
Desmopressin Acetate Injection is indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5%. Desmopressin Acetate Injection will often maintain hemostasis in patients with hemophilia A during surgical procedures and postoperatively when administered 30 minutes prior to scheduled procedure. Desmopressin Acetate Injection will also stop bleeding in hemophilia A patients with episodes of spontaneous or trauma-induced injuries such as hemarthroses, intramuscular hematomas or mucosal bleeding. In certain clinical situations, it may be justified to try Desmopressin Acetate Injection in patients with factor VIII levels between 2% to 5%; however, these patients should be carefully monitored. Desmopressin Acetate Injection is indicated for patients with mild to moderate classic von Willebrand's disease (Type I) with factor VIII levels greater than 5%. Desmopressin Acetate Injection will often maintain hemostasis in patients with mild to moderate von Willebrand's disease during
Desmopressin Acetate Injection, USP is supplied as follows: Desmopressin Acetate Injection, USP is a clear, colorless solution, free from particulate matter filled in a clear glass vial. Store refrigerated between 2° and 8°C (36° and 46°F). Keep out of the reach of children. Sterile, Nonpyrogenic. The container closure is not made with natural rubber latex. SAGENT® Mfd. for SAGENT Pharmaceuticals Schaumburg, IL 60195 (USA) Made in India ©2017 Sagent Pharmaceuticals, Inc. July 2017 SAGENT Pharmaceuticals®
Abbreviated New Drug Application
DESMOPRESSIN ACETATE- DESMOPRESSIN ACETATE INJECTION, SOLUTION SAGENT PHARMACEUTICALS ---------- DESMOPRESSIN ACETATE INJECTION, USP FOR INTRAVENOUS OR SUBCUTANEOUS USE ONLY SAGENT Rx only DESCRIPTION Desmopressin Acetate Injection, USP 4 mcg per mL is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is chemically defined as follows: Mol. Wt. 1183.34 Empirical Formula: C H N O S •C H O •3H O 1-(3-mercaptopropionic acid)-8-D-arginine vasopressin monoacetate (salt) trihydrate. Desmopressin Acetate Injection, USP 4 mcg per mL is provided as a sterile, aqueous solution for intravenous or subcutaneous injection. Each mL provides: The 10 mL vial contains chlorobutanol as a preservative (5 mg per mL). CLINICAL PHARMACOLOGY Desmopressin acetate contains as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin. One mL (4 mcg) of desmopressin acetate solution has an antidiuretic activity of about 16 IU; 1 mcg of desmopressin acetate is equivalent to 4 IU. Desmopressin acetate has been shown to be more potent than arginine vasopressin in increasing plasma levels of factor VIII activity in patients with hemophilia and von Willebrand's disease Type I. Dose-response studies were performed in healthy persons, using doses of 0.1 to 0.4 mcg/kg body weight, infused over a 10-minute period. Maximal dose response occurred at 0.3 to 0.4 mcg/kg. The response to desmopressin acetate of factor VIII activity and plasminogen activator is dose-related, with maximal plasma levels of 300 to 400 percent of initial concentrations obtained after infusion of 0.4 mcg/kg body weight. The increase is rapid and evident within 30 minutes, reaching a maximum at a point ranging from 90 minutes to two hours. The factor VIII related antigen and ristocetin cofactor activity were also increased to a smaller degree, but still are dose-dependent. 1. The biphasic half-lives of desmopressin acetate were 7.8 an Leer el documento completo